Mieke Timmermans - Concepedia

Author

Mieke Timmermans

Also Known As

M TIMMERMANS, M Timmermans, M. A. Timmermans, M. Timmermans, Merel Timmermans, Mieke A Timmermans, Mieke A. M. Timmermans, Mieke A. Timmermans, Mieke A.M. Timmermans, Mieke Timmermans

Publications

5.8K

Citations

H-Index

Concepts

All Affiliations

Erasmus MC Erasmus MC Cancer Institute Erasmus University Rotterdam Cancer Genomics Centre Radboud University Nijmegen

About

Mieke Timmermans is an author at Erasmus MC specializing in medicine, cell biology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	16	4.8K
2	Cell Biology	13	13	4.5K
3	Engineering	2	2	3.9K
4	Natural Sciences	1	1	23
5	Biochemistry	1	1	23

Mieke Timmermans

Publications

5.6K

Citations

H-Index

Page 1

	Year	Citations
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer Yixin Wang, Jan G.M. Klijn, Yi Zhang, The Lancet Radiation OncologyBreast OncologyOncologyEngineeringDistant Metastasis	2005	2.7K
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer Yongyu Wang, J.G.M. Klijn, Y ZHANG, The Lancet Radiation OncologyBreast OncologyOncologyEngineeringDistant Metastasis	2005	1.2K
Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer Dora Hammerl, John W.M. Martens, Mieke Timmermans, Nature Communications Breast OncologyImmunologyImmune RegulationImmunoeditingImmunotherapeutics	2021	229
Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer Antoinette Hollestelle, Justine Peeters, Marcel Smid, Breast Cancer Research and Treatment Epithelial-mesenchymal TransitionTumor BiologyBreast OncologyMedicineMesenchymal Transition	2013	135
Nucleotide Biosynthetic Enzyme GMP Synthase Is a TRIM21-Controlled Relay of p53 Stabilization B. Ashok Reddy, Jan A. van der Knaap, Alice G.M. Bot, Molecular Cell	2014	128
Differential expression of estrogen, progesterone, and epidermal growth factor receptors in normal, benign, and malignant human breast tissues using dual staining immunohistochemistry. T van Agthoven, Mieke Timmermans, John A. Foekens, PubMed	1994	90
Which Cyclin E Prevails as Prognostic Marker for Breast Cancer? Results from a Retrospective Study Involving 635 Lymph Node–Negative Breast Cancer Patients Anieta M. Sieuwerts, Maxime P. Look, Marion E. Meijer‐van Gelder, Clinical Cancer Research	2006	88
How ADAM-9 and ADAM-11 Differentially From Estrogen Receptor Predict Response to Tamoxifen Treatment in Patients with Recurrent Breast Cancer: a Retrospective Study Anieta M. Sieuwerts, Marion E. Meijer‐van Gelder, Mieke Timmermans, Clinical Cancer Research	2005	86
Constitutive expression of γ-H2AX has prognostic relevance in triple negative breast cancer Anika Nagelkerke, Sander M. J. van Kuijk, Fred C.G.J. Sweep, Radiotherapy and Oncology Tumor BiologyBreast OncologyConstitutive ExpressionPrognostic RelevanceMedicine	2011	85
Suppression of rat breast cancer metastasis and reduction of primary tumour growth by the small synthetic urokinase inhibitor WX-UK1 Buddy Setyono-Han, Jörg Stürzebecher, Wolfgang A. Schmalix, Thrombosis and Haemostasis Primary Tumour GrowthOncologyMedicineReceptor UparImmunology	2005	83

Page 1